GVK Biosciences Private Limited
Plot No. 28 A, IDA Nacharam
Hyderabad
500076
Tel: 91-40-6692-9999
Fax: 91-40-6692-9900
Website: http://www.gvkbio.com/
Email: hr@gvkbio.com
About GVK Biosciences Private Limited
Established in 2001, GVK BIO is one of Asia’s leading life sciences service organizations. At GVK BIO, we blend science with people and technology to help accelerate drug discovery and development for more than 400 clients globally across small and large molecule platforms. Our clients include the world’s top 10 corporations in the field of Pharmaceuticals, Biotechnology and Agrochemicals along with leading Academic institutions.YEAR FOUNDED:
2001
LEADERSHIP:
Founder: GVK Reddy
CEO: Manni Kantipudi
CSO: J. B. Gupta
CFO: Paresh Gupta
CHO: Suresh Anubolu
JOBS:
Please click here for GBK Bio job opportunities.
FOLLOW GVK BIO:
Tweets by GVK Bio
20 articles with GVK Biosciences Private Limited
-
Aragen (Formerly GVK BIO) to Partner With Global Biopharma With a Renewed Brand Promise
6/2/2021
Aragen Life Sciences (Aragen), formerly known as GVK Biosciences and a leading contract research, development and manufacturing organization, officially marked its transition to a new brand identity. With a legacy of over 20 years of partnering with innovator life sciences companies around the world, Aragen is poised for growth in the outsourced discovery, development, and manufacturing services sector across both large and small molecule platforms.
-
Serum Institute and Aragen Bioscience Announce Collaboration on Vaccine Development
1/8/2020
Aragen Bioscience, Inc and Serum Institute of India Pvt. Ltd. are pleased to announce a collaboration for the development of multiple stable cell lines to support Serum’s HIV program.
-
GVK Bio continues to see growth tailwinds for 2020 thanks to a ‘crescendo of factors’
11/5/2019
China-US trade challenges has led to de-risking by pharma companies
-
GVK BIO Announces the Promotion of Sudhir Kumar Singh to Chief Operating Officer and Appointment of Ramesh Subramanian as the New Chief Commercial Officer of GVK BIO
9/4/2019
Sudhir joined GVK BIO in 2013 as a Senior Vice President and has been driving the Discovery Research business.
-
GVK BIO Announces Launch Of A GMP Compliant Analytical Services Laboratory
12/1/2016
-
FDA Extends License of the gvk bioSciences Private Limited Biomarker Database
2/4/2013
-
gvk bioSciences Private Limited Enters Into Research Collaboration With Endo Pharmaceuticals
1/28/2013
-
gvk bioSciences Private Limited and Onconova Therapeutics Inc. Establish Novel Joint Development Partnership to Advance New Drugs for Cancer
1/9/2013
-
gvk bioSciences Private Limited Licenses its Biomarker Database to the Division of Cancer Prevention, National Cancer Institute
9/4/2012
-
gvk bioSciences Private Limited' Ahmedabad Clinical Pharmacology Unit Successfully Clears the FDA Audit
7/30/2012
-
gvk bioSciences Private Limited Announces Multi-year Drug Discovery Collaboration with the Moulder Center for Drug Discovery Research, Temple University
11/28/2011
-
gvk bioSciences Private Limited Presented the Frost & Sullivan Growth Leadership Award in Contract Research Service Market
11/21/2011
-
gvk bioSciences Private Limited Partners With the PROOF Centre of Excellence, University of British Columbia in Biomarker Development and Commercialization
11/15/2011
-
gvk bioSciences Private Limited Extends the License of its SAR Databases to Astellas Pharma Inc.
10/24/2011
-
Indiana CTSI Partners With gvk bioSciences Private Limited to Provide National Access to Biomarkers Database
6/8/2011
-
gvk bioSciences Private Limited Extends License of its Biomarker Database to the US FDA
4/25/2011
-
gvk bioSciences Private Limited Opens new Clinical Pharmacology Unit in Ahmedabad
3/18/2010
-
Dr. Cecil B. Pickett Joins the gvk bioSciences Private Limited Scientific Advisory Board
12/14/2009
-
Bayer CropScience AG Signs Agreement with gvk bioSciences Private Limited on Early-Stage Research Projects
11/24/2009
-
gvk bioSciences Private Limited Forms Clinical Research Alliance with Excel PharmaStudies, to Conduct Trials in India and China
4/14/2009